Nisa Ya, Heidi Auerswald, Sothy Touch, Saraden In, Chanvannak Yun, Pisey Thai, Sotheary Sann, Borita Heng, Chanthy Leng, Veasna Duong, Yik Sing Peng, Sowath Ly, Tineke Cantaert
{"title":"狗咬伤病例暴露后狂犬病预防后一年免疫力评估。","authors":"Nisa Ya, Heidi Auerswald, Sothy Touch, Saraden In, Chanvannak Yun, Pisey Thai, Sotheary Sann, Borita Heng, Chanthy Leng, Veasna Duong, Yik Sing Peng, Sowath Ly, Tineke Cantaert","doi":"10.1038/s41541-024-01030-8","DOIUrl":null,"url":null,"abstract":"<p><p>Rabies remains a global health threat despite being preventable with post-exposure prophylaxis (PEP). This study assessed one-year humoral and T cell immunity in PEP recipients of the Insitut Pasteur du Cambodge (IPC) regimen, recommended by WHO. We analyzed rabies virus (RABV) neutralizing antibodies (nAbs) and T cell responses at baseline, 7 and 14 days, 6 and 12 months after PEP. A total of 148 patients were included, with 78 bitten by confirmed RABV-positive dogs receiving PEP and equine rabies immunoglobulins (eRIG), and 70 bitten by RABV-negative dogs receiving only PEP. Fourteen days after PEP, all but two individuals seroconverted for nAbs ( ≥ 0.5 IU/mL) with 87% maintaining this response even after 12 months. Interleukin-4 (IL-4) and interferon-gamma (IFN-γ)-secreting T cells were significantly elevated after 14 days and sustained for one year. No differences were observed between the RABV-exposed and -unexposed groups. This study demonstrates robust one-year immunity after IPC PEP.</p>","PeriodicalId":19335,"journal":{"name":"NPJ Vaccines","volume":"9 1","pages":"237"},"PeriodicalIF":6.9000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11603308/pdf/","citationCount":"0","resultStr":"{\"title\":\"Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases.\",\"authors\":\"Nisa Ya, Heidi Auerswald, Sothy Touch, Saraden In, Chanvannak Yun, Pisey Thai, Sotheary Sann, Borita Heng, Chanthy Leng, Veasna Duong, Yik Sing Peng, Sowath Ly, Tineke Cantaert\",\"doi\":\"10.1038/s41541-024-01030-8\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Rabies remains a global health threat despite being preventable with post-exposure prophylaxis (PEP). This study assessed one-year humoral and T cell immunity in PEP recipients of the Insitut Pasteur du Cambodge (IPC) regimen, recommended by WHO. We analyzed rabies virus (RABV) neutralizing antibodies (nAbs) and T cell responses at baseline, 7 and 14 days, 6 and 12 months after PEP. A total of 148 patients were included, with 78 bitten by confirmed RABV-positive dogs receiving PEP and equine rabies immunoglobulins (eRIG), and 70 bitten by RABV-negative dogs receiving only PEP. Fourteen days after PEP, all but two individuals seroconverted for nAbs ( ≥ 0.5 IU/mL) with 87% maintaining this response even after 12 months. Interleukin-4 (IL-4) and interferon-gamma (IFN-γ)-secreting T cells were significantly elevated after 14 days and sustained for one year. No differences were observed between the RABV-exposed and -unexposed groups. This study demonstrates robust one-year immunity after IPC PEP.</p>\",\"PeriodicalId\":19335,\"journal\":{\"name\":\"NPJ Vaccines\",\"volume\":\"9 1\",\"pages\":\"237\"},\"PeriodicalIF\":6.9000,\"publicationDate\":\"2024-11-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11603308/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NPJ Vaccines\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41541-024-01030-8\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41541-024-01030-8","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
尽管暴露后预防(PEP)可以预防狂犬病,但狂犬病仍然是全球健康的威胁。本研究评估了接受世界卫生组织推荐的柬埔寨巴斯德研究所(IPC)方案的 PEP 受试者一年的体液免疫和 T 细胞免疫情况。我们分析了狂犬病病毒 (RABV) 中和抗体 (nAbs) 和 T 细胞在 PEP 后基线、7 天和 14 天、6 个月和 12 个月的反应。我们共纳入了 148 名患者,其中 78 人被确诊为 RABV 阳性的狗咬伤,接受了 PEP 和马狂犬病免疫球蛋白 (eRIG),70 人被 RABV 阴性的狗咬伤,只接受了 PEP。PEP 14 天后,除两人外,其他所有人都出现了 nAbs 血清转换(≥ 0.5 IU/mL),其中 87% 的人在 12 个月后仍能保持这种反应。分泌白细胞介素-4(IL-4)和γ干扰素(IFN-γ)的 T 细胞在 14 天后显著升高,并持续一年。在接触过 RABV 和未接触过 RABV 的组别之间未观察到差异。这项研究证明了 IPC PEP 一年后的强大免疫力。
Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases.
Rabies remains a global health threat despite being preventable with post-exposure prophylaxis (PEP). This study assessed one-year humoral and T cell immunity in PEP recipients of the Insitut Pasteur du Cambodge (IPC) regimen, recommended by WHO. We analyzed rabies virus (RABV) neutralizing antibodies (nAbs) and T cell responses at baseline, 7 and 14 days, 6 and 12 months after PEP. A total of 148 patients were included, with 78 bitten by confirmed RABV-positive dogs receiving PEP and equine rabies immunoglobulins (eRIG), and 70 bitten by RABV-negative dogs receiving only PEP. Fourteen days after PEP, all but two individuals seroconverted for nAbs ( ≥ 0.5 IU/mL) with 87% maintaining this response even after 12 months. Interleukin-4 (IL-4) and interferon-gamma (IFN-γ)-secreting T cells were significantly elevated after 14 days and sustained for one year. No differences were observed between the RABV-exposed and -unexposed groups. This study demonstrates robust one-year immunity after IPC PEP.
NPJ VaccinesImmunology and Microbiology-Immunology
CiteScore
11.90
自引率
4.30%
发文量
146
审稿时长
11 weeks
期刊介绍:
Online-only and open access, npj Vaccines is dedicated to highlighting the most important scientific advances in vaccine research and development.